Journal of Physical Therapy and Sports Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +447723862070

Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients

4th Euro-Global Physiotherapy Congress 2017
December 07-08, 2017 Rome, Italy

Wael Abo El-kheir, Hala Gabr, Mohamed Reda Awad, Osama Ghannam, Yousef Barakat, Haithem A M A Farghali, Zeinab M El Maadawi, Ibrahim Ewes and Hatem E Sabaawy

Military Medical Academy, Egypt Cairo University, Cairo, Egypt Al-Azhar University, Cairo, Egypt Al-Azhar University, Cairo, Egypt Cairo University, Cairo, Egypt Department of Histology, Egypt Rutgers–Cancer Institute of New Jersey, USA

Scientific Tracks Abstracts : J Phys Ther Sports Med


Spinal cord injuries (SCI) cause sensory loss and motor paralysis and are treated with physical therapy, but most patients fail to recover due to limited neural regeneration. Here we describe a strategy in which treatment with autologous adherent bone marrow cells is combined with physical therapy to improve motor and sensory functions in early-stage chronic SCI patients. In a phase I/II controlled single-blind clinical trial (clinicaltrials. gov identifier: NCT00816803), 70 chronic cervical and thoracic SCI patients with injury durations of at least 6 months were treated with either intrathecal injection(s) of autologous adherent bone marrow cells combined with physical therapy, or with physical therapy alone. Patients were evaluated with clinical examinations, electrophysiological somatosensory evoked potential, MRI imaging, and functional independence measurements. Chronic cervical and thoracic SCI patients treated with autologous adherent bone marrow cells combined with physical therapy showed functional improvements over patients in the control group treated with physical therapy alone, and there were no cell therapy-related side effects. At 18 months posttreatment, 23 of the 50 cell therapy-treated cases (46 percent) showed sustained improvement using the American Spinal Injury Association (ASIA) Impairment Scale (AIS). Compared to those patients with cervical injuries, a higher rate of functional improvement was achieved in thoracic SCI patients with shorter durations of injury and smaller cord lesions. Therefore, when combined with physical therapy, autologous adherent bone marrow cell therapy appears to be a safe and promising therapy for patients with chronic spinal cord injuries. Randomized controlled multicenter trials are warranted.


Wael Abo El-Kheir is currently works as Professor of immunology & Microbiology in military medical academy and he is the member of the national committee for stem cells Egyptian ministry of health and also honor as secretary of the Egyptian society of stem cells.

Get the App